A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer...

Saved in:

Published in:	BMC cancer 12(2012) Artikel-Nummer 108, 6 Seiten
Authors and Corporations:	Berger, Anne Katrin (Author), Abel, Ulrich (Author), Kloor, Matthias (Author), Ose, Jennifer (Author), Weber, Tim (Author), Stange, Annika (Author), Haag, Georg Martin (Author), Haberkorn, Uwe (Author), Jäger, Dirk (Author)
Title:	A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial/ Anne Katrin Berger, Carl von Gall, Ulrich Abel, Stefan Delorme, Matthias Kloor, Jennifer Ose, Tim Frederik Weber, Annika Stange, Georg Martin Haag, Uwe Haberkorn, Florian Lordick, Dirk Jäger
Type of Resource:	E-Book Component Part
Language:	English
published:	22 March 2012
Series:	: BMC cancer, 12(2012) Artikel-Nummer 108, 6 Seiten , volume:12
Subjects:	18F-FDG PET CT Cetuximab Colorectal cancer Metabolic imaging Metastases
Source:	Verbunddaten SWB Lizenzfreie Online-Ressourcen

Internet

Full Text